Depressive reactions to lung cancer are common and often followed by a poor outcome

被引:85
作者
Buccheri, G [1 ]
机构
[1] Osped A Carle, Div Pulm 2, I-12100 Cuneo, Italy
关键词
lung cancer; mental depression; prognosis;
D O I
10.1183/09031936.98.11010173
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
In diverse human malignancies, including lung cancer, quality of life (QOL) affects the clinical outcome of patients, Many QOL dimensions, however, are influenced by physical status. The current study was undertaken to delineate the role of depression, a state of mind not necessarily influenced by somatic factors. All patients, seen for a newly diagnosed carcinoma of the lung, received a copy of the Self-rating Depression Scale (SDS) proposed by W.W.K. Zung. One hundred and thirty three patients were able and willing to complete the questionnaire, A depression index was calculated, as originally described. Nineteen other prognostically important variables were recorded and available for evaluation. Among the 95 patients who completed all 20 items included in the questionnaire, 53 had an SDS index less than or equal to 50 (no depression), while 42 were moderately or severely depressed (SDS index >50). The survival of depressed patients was significantly lower (p=0.048). Diverse SDS subscales were associated with survival, in either univariate or multivariate analysis, SDS item 19, "I feel that others would be better off if I were dead", emerged as the most significant one. A multivariate model of survival, constructed using only SDS data, had a global Chi-squared value of 29.78, and a p-value of 0.00023. Based on this evidence, it appears that a relationship does exist between patients' depression and prognosis, at least in lung cancer. Further studies are needed to clarify the prognostic effect of depression in more specific (and homogeneous) subgroups of patients.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 33 条
[1]   THE EORTC QLQ-LC13 - A MODULAR SUPPLEMENT TO THE EORTC CORE QUALITY-OF-LIFE QUESTIONNAIRE (QLQ-C30) FOR USE IN LUNG-CANCER CLINICAL-TRIALS [J].
BERGMAN, B ;
AARONSON, NK ;
AHMEDZAI, S ;
KAASA, S ;
SULLIVAN, M .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) :635-642
[2]   PROGNOSTIC FACTORS IN LUNG-CANCER - TABLES AND COMMENTS [J].
BUCCHERI, G ;
FERRIGNO, D .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (07) :1350-1364
[3]   CARCINOEMBRYONIC ANTIGEN (CEA), TISSUE POLYPEPTIDE ANTIGEN (TPA) AND OTHER PROGNOSTIC INDICATORS IN SQUAMOUS-CELL LUNG-CANCER [J].
BUCCHERI, G ;
FERRIGNO, D ;
VOLA, F .
LUNG CANCER, 1993, 10 (1-2) :21-33
[4]   DIAGNOSTIC, MORPHOLOGICAL, AND HISTOPATHOLOGIC CORRELATES IN BRONCHOGENIC-CARCINOMA - A REVIEW OF 1,045 BRONCHOSCOPIC EXAMINATIONS [J].
BUCCHERI, G ;
BARBERIS, P ;
DELFINO, MS .
CHEST, 1991, 99 (04) :809-814
[5]   PROGNOSTIC VALUE OF THE TISSUE POLYPEPTIDE ANTIGEN IN LUNG-CANCER [J].
BUCCHERI, G ;
FERRIGNO, D .
CHEST, 1992, 101 (05) :1287-1292
[6]   Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer [J].
Buccheri, G ;
Biggi, A ;
Ferrigno, D ;
Quaranta, M ;
Leone, A ;
Vassallo, G ;
Pugno, F .
THORAX, 1996, 51 (04) :359-363
[7]  
BUCCHERI G, 1995, SUPP CARE ONCOL, V16, P11
[8]   THE PATIENTS PERCEPTION OF HIS OWN QUALITY-OF-LIFE MIGHT HAVE AN ADJUNCTIVE PROGNOSTIC-SIGNIFICANCE IN LUNG-CANCER [J].
BUCCHERI, GF ;
FERRIGNO, D ;
TAMBURINI, M ;
BRUNELLI, C .
LUNG CANCER, 1995, 12 (1-2) :45-58
[9]  
BUCCHERI GF, 1993, INT J ONCOL, V2, P537
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187